[1] Hwan YJ, Shin J, Jin YJ,et al. Comparison of clinical manifestations and outcomes of noncirrhotic and cirrhotic hepatocellular carcinoma patients with chronic hepatitis B. Eur J Gastroenterol Hepatol, 2020, 32(1):66-73. [2] 赵小利,秦博,李东风,等.乙型肝炎肝硬化并发食管静脉曲张患者超声检测肝脏血流参数和红细胞分布宽度与淋巴细胞比值变化.实用肝脏病杂志,2023,26(4):528-531. [3] Ballestri S, Tana C, Di Girolamo M,et al. Semi-quantitative ultrasonographic evaluation of NAFLD. Curr Pharm Des, 2020,26(32):3915-3927. [4] Ibacahe C, Correa-Burrows P, Burrows R,et al. Accuracy of a semi-quantitative ultrasound method to determine liver fat infiltration in early adulthood. Diagnostics (Basel), 2020, 10(6):431. [5] Zheng Y, Xia S, Ren X,et al. A study of spleen shear-wave elastography in indirect prediction of liver fibrosis in patients with chronic hepatitis B. Clin Hemorheol Microcirc,2020,76(1):63-72. [6] Yang L, Li J, Ma L,et al. Noninvasive assessment of liver fibrosis in chronic hepatitis B carriers with sound touch elastography: study of surgical pathology specimens. Expert Rev Med Devices, 2020, 17(8):845-853. [7] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2022年版). 中华肝脏病杂志,2022,30(12):1309-1331. [8] 李响,张铁英,张旭辉,等. 基于超声参数的半定量评分评估乙型肝炎肝硬化食管静脉曲张价值探讨. 实用肝脏病杂志,2022,25(6):857-860. [9] Shanshan W, Xinfang D, Shuihong Y, et al. Pathological changes of liver one year later in CHB patients with negative HBV DNA. InfectAgent Cancer, 2019,10(14):48. [10] World Health Organization. Hepatitis B [Internet] Geneva: World Health Organization; 2019. [cited 2024 Dec 26] . Available from:https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. [11] Cao G, Jing W, Liu J, et al. Countdown on hepatitis B elimination by 2030: the global burden of liver disease related to hepatitis B and association with socioeconomic status. Hepatol Int, 2022, 16(6):1282-1296. [12] Polaris Observatory Collaborators. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol, 2023 ,8(10):879-907. [13] Wang J, Wu M, Linghu R,et al. Usefulness of new shear wave elastography technique for noninvasive assessment of liver fibrosis in patients with chronic hepatitis B: A prospective multicenter study. Ultraschall Med, 2022, 43(2):e1-e10. [14] Zhang YN, Fowler KJ, Ozturk A,et al. Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography. J Magn Reson Imaging, 2020, 51(1):25-42. [15] Li J, Liu H, Zhang C,et al. Native T1 mapping compared to ultrasound elastography for staging and monitoring liver fibrosis: an animal study of repeatability, reproducibility, and accuracy. Eur Radiol, 2020, 30(1):337-345. [16] 魏倩,赵林,付宁,等. 彩色多普勒超声检查早期诊断乙型肝炎肝硬化价值研究. 实用肝脏病杂志,2019,22(3):413-416. [17] Yang J, Li J, Ye G,et al. Comparison of visual transient elastography and shear wave elastography in evaluating liver fibrosis in patients with chronic liver disease. Int J Gen Med, 2021, 14:3553-3561. [18] Xiang H, Ling W, Ma L,et al. Shear wave elastography using sound touch elastography and supersonic shear imaging for liver measurements: a comparative study. Quant Imaging Med Surg,2022, 12(5):2855-2865. [19] Wong RJ, Jain MK, Therapondos G,et al. Sustained improvements in markers of liver disease severity after hepatitis C treatment. J Clin Exp Hepatol, 2020, 10(2):114-123. [20] Luo H, Peng S, Ouyang W,et al. Assessment of liver fibrosis by transient elastography and multi-parameters model in young children with chronic hepatitis B virus infection. BMC Infect Dis, 2022, 22(1):160. [21] Luo J, Du Z, Liang D,et al. Gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease. J Clin Lab Anal, 2022, 36(8):e24596. [22] Huang K, Li Q, Zeng W,et al. Ultrasound score combined with liver stiffness measurement by sound touch elastography for staging liver fibrosis in patients with chronic hepatitis B: a clinical prospective study. Ann Transl Med, 2022, 10(6):271. |